Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT

Carmen Martíneza Department of Hematology, Institute of Hematology and Oncology, Hospital Clínic, Barcelona, SpainCorrespondence[email protected]

Ariane Boumendilb EBMT LWP Paris Office Hopital Saint-Antoine, Paris, France

Joanna Romejko-Jarosinskac Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Achilles Anagnostopoulosd George Papanicolaou General Hospital, Thessaloniki, Greece

Edgar Fabere University Hospital, Olomouc, Czech Republic

Xavier Poiréf Cliniques Universitaires St. Luc, Brussels, Belgium

Ibrahim Yakoub-Aghag Hôpital Huriez, Lille, France

Saad Akhtarh King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Gunhan Gurmani Faculty of Medicine, Ankara University, Ankara, Turkey

Vincenzo Pavonej Hospital C. Panico, Tricaze, Italy

Kazimierz Halaburdak Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Aida Botelho Sousal Hospital dos Capuchos, Lisboa, Portugal

Hervé Ghesquièresm Hospices Civils, Lyon, France

Hervé Finelb EBMT LWP Paris Office Hopital Saint-Antoine, Paris, France

Irma Khvedelidzeb EBMT LWP Paris Office Hopital Saint-Antoine, Paris, France

Silvia Montoton Department of Haemato-Oncology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

Anna Suredao Department of Haematology, Institut Catala d’Oncologia, Hospital Duran I Reynals, Barcelona, Spain

Your download is now in progress and you may close this window